Vanesa Lafarga

2.8k total citations
32 papers, 1.4k citations indexed

About

Vanesa Lafarga is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Vanesa Lafarga has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Vanesa Lafarga's work include DNA Repair Mechanisms (8 papers), RNA modifications and cancer (7 papers) and Ubiquitin and proteasome pathways (7 papers). Vanesa Lafarga is often cited by papers focused on DNA Repair Mechanisms (8 papers), RNA modifications and cancer (7 papers) and Ubiquitin and proteasome pathways (7 papers). Vanesa Lafarga collaborates with scholars based in Spain, Sweden and United States. Vanesa Lafarga's co-authors include Óscar Fernández-Capetillo, Petronila Penela, Federico Mayor, Ana Cuadrado, Ángel R. Nebreda, Rocío Bengoechea, Cristina Murga, Catalina Ribas, Isabel López de Silanes and O. Tapia and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Vanesa Lafarga

32 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanesa Lafarga Spain 18 1.2k 368 126 123 97 32 1.4k
Amila Suraweera Australia 16 1.3k 1.1× 302 0.8× 155 1.2× 168 1.4× 142 1.5× 25 1.6k
Wojciech Michowski United States 16 817 0.7× 271 0.7× 150 1.2× 165 1.3× 59 0.6× 20 1.1k
Zhenyu Ji United States 15 901 0.8× 394 1.1× 138 1.1× 92 0.7× 101 1.0× 40 1.2k
Julianne L. Holleran United States 18 1.0k 0.9× 356 1.0× 75 0.6× 206 1.7× 114 1.2× 55 1.4k
Sachin Katyal Canada 19 1.6k 1.4× 463 1.3× 221 1.8× 126 1.0× 155 1.6× 35 1.8k
Ewa Stępniak-Konieczna Poland 13 1.0k 0.9× 224 0.6× 162 1.3× 147 1.2× 240 2.5× 16 1.3k
Erik Wilker United States 16 1.1k 0.9× 268 0.7× 95 0.8× 270 2.2× 61 0.6× 24 1.5k
Ron de Jong United States 19 1.1k 0.9× 289 0.8× 78 0.6× 154 1.3× 73 0.8× 33 1.6k
Jean‐Bernard Lazaro United States 16 701 0.6× 385 1.0× 95 0.8× 125 1.0× 75 0.8× 32 961
Gautam Sondarva United States 18 840 0.7× 240 0.7× 92 0.7× 139 1.1× 78 0.8× 28 1.1k

Countries citing papers authored by Vanesa Lafarga

Since Specialization
Citations

This map shows the geographic impact of Vanesa Lafarga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanesa Lafarga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanesa Lafarga more than expected).

Fields of papers citing papers by Vanesa Lafarga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanesa Lafarga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanesa Lafarga. The network helps show where Vanesa Lafarga may publish in the future.

Co-authorship network of co-authors of Vanesa Lafarga

This figure shows the co-authorship network connecting the top 25 collaborators of Vanesa Lafarga. A scholar is included among the top collaborators of Vanesa Lafarga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanesa Lafarga. Vanesa Lafarga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rivas, Verónica, et al.. (2024). GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner. Cell Death Discovery. 10(1). 385–385. 3 indexed citations
2.
Zarzuela, Eduardo, et al.. (2024). Nucleolar stress caused by arginine-rich peptides triggers a ribosomopathy and accelerates aging in mice. Molecular Cell. 84(8). 1527–1540.e7. 15 indexed citations
3.
Sánchez, Jana, Fernando Garcı́a, Begoña Hurtado, et al.. (2023). Decoding protein methylation function with thermal stability analysis. Nature Communications. 14(1). 3016–3016. 5 indexed citations
4.
Lafarga, Vanesa, et al.. (2022). Targeting the nucleolus as a therapeutic strategy in human disease. Trends in Biochemical Sciences. 48(3). 274–287. 41 indexed citations
5.
Kanellis, Dimitris C., Patrycja Michalska, Maria Häggblad, et al.. (2021). A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors. PLoS Biology. 19(5). e3001263–e3001263. 5 indexed citations
6.
Berciano, Marı́a T., J. Fernando Val‐Bernal, Vanesa Lafarga, et al.. (2020). Mislocalization of SMN from the I-band and M-band in human skeletal myofibers in spinal muscular atrophy associates with primary structural alterations of the sarcomere. Cell and Tissue Research. 381(3). 461–478. 10 indexed citations
7.
Baltanás, Fernando C., Marı́a T. Berciano, O. Tapia, et al.. (2019). Nucleolin reorganization and nucleolar stress in Purkinje cells of mutant PCD mice. Neurobiology of Disease. 127. 312–322. 10 indexed citations
8.
Morales, Carmen del Rocío Monedero, Sara Rodríguez‐Acebes, Vanesa Lafarga, et al.. (2019). PDS5 proteins are required for proper cohesin dynamics and participate in replication fork protection. Journal of Biological Chemistry. 295(1). 146–157. 44 indexed citations
9.
Lafarga, Vanesa, Katharina Haneke, Anne‐Laure Pauleau, et al.. (2018). TIAR marks nuclear G2/M transition granules and restricts CDK 1 activity under replication stress. EMBO Reports. 20(1). 15 indexed citations
10.
Day, Amanda, Matilde Murga, Vanesa Lafarga, et al.. (2016). Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL -rearranged AML. Science Signaling. 9(445). ra91–ra91. 46 indexed citations
11.
Ruiz, Sergio, Cristina Mayor‐Ruiz, Vanesa Lafarga, et al.. (2016). A Genome-wide CRISPR Screen Identifies CDC25A as a Determinant of Sensitivity to ATR Inhibitors. Molecular Cell. 62(2). 307–313. 152 indexed citations
12.
Lafarga, Vanesa, Emilio Lecona, Matilde Murga, et al.. (2016). Efficacy of ATR inhibitors as single agents in Ewing sarcoma. Oncotarget. 7(37). 58759–58767. 59 indexed citations
13.
Ballester, Alicia, Vanesa Lafarga, Anaïs Jiménez-Reinoso, et al.. (2012). Intraepithelial paracrine Hedgehog signaling induces the expansion of ciliated cells that express diverse progenitor cell markers in the basal epithelium of the mouse mammary gland. Developmental Biology. 372(1). 28–44. 36 indexed citations
14.
15.
Lafarga, Vanesa, Federico Mayor, & Petronila Penela. (2012). The interplay between G protein-coupled receptor kinase 2 (GRK2) and histone deacetylase 6 (HDAC6) at the crossroads of epithelial cell motility. Cell Adhesion & Migration. 6(6). 495–501. 16 indexed citations
16.
Lafarga, Vanesa, Ivette Aymerich, O. Tapia, Federico Mayor, & Petronila Penela. (2011). A novel GRK2/HDAC6 interaction modulates cell spreading and motility. The EMBO Journal. 31(4). 856–869. 103 indexed citations
17.
Baltanás, Fernando C., Íñigo Casafont, Vanesa Lafarga, et al.. (2011). Purkinje Cell Degeneration in pcd Mice Reveals Large Scale Chromatin Reorganization and Gene Silencing Linked to Defective DNA Repair. Journal of Biological Chemistry. 286(32). 28287–28302. 45 indexed citations
18.
Penela, Petronila, Cristina Murga, Catalina Ribas, Vanesa Lafarga, & Federico Mayor. (2010). The complex G protein‐coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. British Journal of Pharmacology. 160(4). 821–832. 178 indexed citations
19.
Lafarga, Vanesa, Ana Cuadrado, & Ángel R. Nebreda. (2007). p18HamletMediates Different p53-Dependent Responses to DNA Damage Inducing Agents. Cell Cycle. 6(19). 2319–2322. 15 indexed citations
20.
Cuadrado, Ana, Vanesa Lafarga, Peter Cheung, et al.. (2007). A new p38 MAP kinase‐regulated transcriptional coactivator that stimulates p53‐dependent apoptosis. The EMBO Journal. 26(8). 2115–2126. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amila Suraweera Breakdown of academic impact, for papers by Wojciech Michowski Breakdown of academic impact, for papers by Zhenyu Ji Breakdown of academic impact, for papers by Julianne L. Holleran Breakdown of academic impact, for papers by Sachin Katyal Breakdown of academic impact, for papers by Ewa Stępniak-Konieczna Breakdown of academic impact, for papers by Erik Wilker Breakdown of academic impact, for papers by Ron de Jong Breakdown of academic impact, for papers by Jean‐Bernard Lazaro Breakdown of academic impact, for papers by Gautam Sondarva
Rankless by CCL
2026